EW Healthcare Partners invested in Cognate BioServices.

Private equity firm EW Healthcare Partners invested in Cognate BioServices, a leading contract development and manufacturing organization in the global cellular therapies industry. Financial terms were not disclosed. "We have known Cognate and followed its progress for a while and have been very impressed with the way in which the management team of Cognate has developed the business. Looking toward the future, the Company's strategic plans are quite compelling and well aligned with our long term vision for the Company. We look forward to supporting the Cognate team as it continues to execute on its vision," commented Evis Hursever, Managing Director of EW Healthcare.